BIOXYNE LIMITED - Announcements

12.9%

2.7¢

Market Cap $58.45M

Healthcare Biotechnology Cannabis

Bioxyne Limited is an Australia-based international consumer health and pharmaceutical... Bioxyne Limited is an Australia-based international consumer health and pharmaceutical company. The Company is focused on health and wellness products, psychotropic and investigational medicines. The Company operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, and Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The Company direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.More

NATURAL MEDICINE LEADERS

The Calmer Co (ASX:CCO) pens agreement with Leilo

Announcements

Filter Results

All Price Sensitive Only

BXN	Bioxyne to Host Webinar 18 June 2025 at 5PM AEST		12/06/25	163.92KB	Share
BXN	FY25 Revenue Guidance Upgrade	PRICE SENSITIVE	12/06/25	163.29KB	Share
BXN	Invitation to Investor Webinar 1 May 2025 at 4PM AEST		30/04/25	242.31KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/04/25	521.79KB	Share
BXN	Notification regarding unquoted securities - BXN		07/04/25	17.73KB	Share
BXN	Notification regarding unquoted securities - BXN		07/04/25	17.73KB	Share
BXN	Notification regarding unquoted securities - BXN		07/04/25	18.02KB	Share
BXN	Prof Michael Barnes MD, FRCP Joins BXN Advisory Board		03/04/25	209.24KB	Share
BXN	BXN Signs Exclusive $7m Manufacturing and Supply Agreement	PRICE SENSITIVE	03/04/25	205.72KB	Share
BXN	Cleansing Notice		27/03/25	174.63KB	Share
BXN	Application for quotation of securities - BXN		27/03/25	15.64KB	Share
BXN	Proposed issue of securities - BXN		21/03/25	15.93KB	Share
BXN	Proposed issue of securities - BXN		21/03/25	15.98KB	Share
BXN	Proposed issue of securities - BXN		21/03/25	18.55KB	Share
BXN	Bioxyne Raises A$3 million in Capital Raise	PRICE SENSITIVE	21/03/25	267.09KB	Share
BXN	Trading Halt	PRICE SENSITIVE	19/03/25	203.74KB	Share
BXN	Pause in Trading	PRICE SENSITIVE	19/03/25	113.73KB	Share
BXN	Bioxyne Investor Webinar 5 March		04/03/25	243.8KB	Share
BXN	BXN H1 FY25 Results Presentation	PRICE SENSITIVE	28/02/25	2.06MB	Share
BXN	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/25	2.2MB	Share
BXN	Quarterly Activities Report December 2024 Revised	PRICE SENSITIVE	28/01/25	496.25KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/01/25	445.81KB	Share
BXN	Revenue Guidance	PRICE SENSITIVE	23/01/25	270.77KB	Share
BXN	Addendum to Presentation dated 18 November 2024	PRICE SENSITIVE	14/01/25	187.03KB	Share
BXN	Change of Directors Interest Notice X 3		19/12/24	244.59KB	Share
BXN	Notification regarding unquoted securities - BXN		19/12/24	16.86KB	Share
BXN	Notification of cessation of securities - BXN		19/12/24	12.66KB	Share
BXN	Notification regarding unquoted securities - BXN		19/12/24	18.16KB	Share
BXN	Response to ASX Price Query	PRICE SENSITIVE	28/11/24	1.27MB	Share
BXN	Results of Meeting Revised		27/11/24	655.14KB	Share
BXN	Results of Meeting		21/11/24	600.14KB	Share
BXN	Investor Presentation November 2024	PRICE SENSITIVE	18/11/24	1.94MB	Share
BXN	AGM Change of Venue and Registration		18/11/24	669.18KB	Share
BXN	Cleansing Notice		08/11/24	677.22KB	Share
BXN	Notification regarding unquoted securities - BXN		01/11/24	15.56KB	Share
BXN	Application for quotation of securities - BXN		01/11/24	16.8KB	Share
BXN	Letter to Shareholders re Notice of Annual General Meeting		22/10/24	610.24KB	Share
BXN	Notice of Annual General Meeting/Proxy Form		22/10/24	559.05KB	Share
BXN	Investor Presentation Update	PRICE SENSITIVE	17/10/24	2.17MB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	17/10/24	501.16KB	Share
BXN	AGM Date and Director Nominations		04/10/24	185.21KB	Share
BXN	Annual Report to shareholders		30/09/24	2.08MB	Share
BXN	Appendix 4G - Corporate Governance Statement		30/09/24	610.58KB	Share
BXN	Bioxyne Investor Webinar 25 September 2024		24/09/24	228.25KB	Share
BXN	Bioxyne Extends Contract with Aura Therapeutics	PRICE SENSITIVE	24/09/24	179.74KB	Share
BXN	JMM Webinar Presentation		18/09/24	3.22MB	Share
BXN	Response to ASX Aware Query	PRICE SENSITIVE	18/09/24	1.26MB	Share
BXN	Reinstatement to Quotation	PRICE SENSITIVE	18/09/24	87.92KB	Share
BXN	Announcement 21.8.2024 Clarifying Statement	PRICE SENSITIVE	18/09/24	219.98KB	Share
BXN	Suspension from Official Quotation	PRICE SENSITIVE	13/09/24	110.25KB	Share
BXN	Preliminary Final Report	PRICE SENSITIVE	30/08/24	607.71KB	Share
BXN	Response to ASX Query Letter	PRICE SENSITIVE	23/08/24	1.29MB	Share
BXN	Pause in Trading	PRICE SENSITIVE	23/08/24	116.54KB	Share
BXN	BXN Manufactures First Pharmaceutical Cannabis Gummies	PRICE SENSITIVE	21/08/24	183.66KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/24	1.02MB	Share
BXN	Addendum to Cy Biopharma Announcement 14.5.2024		01/07/24	253.63KB	Share
BXN	BXN Signs Collaboration Agreement with Cy Biopharma AG		14/05/24	290.26KB	Share
BXN	Shares Out of Escrow		13/05/24	647.43KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	985.45KB	Share
BXN	Cleansing Notice		22/04/24	675.74KB	Share
BXN	Application for quotation of securities - BXN		22/04/24	15.39KB	Share
BXN	Proposed issue of securities - BXN		18/04/24	15.15KB	Share
BXN	Bioxyne Receives Firm Commitments to Raise $1.45 Million		18/04/24	702.1KB	Share
BXN	Bioxyne to Host Webinar on 28 March 2024		25/03/24	667.26KB	Share
BXN	Investor Presentation		25/03/24	4.86MB	Share
BXN	Notification regarding unquoted securities - BXN		22/03/24	15.56KB	Share
BXN	Notification of cessation of securities - BXN		22/03/24	12.69KB	Share
BXN	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/24	2.39MB	Share
BXN	BXN Awarded GMP Manufacturing License for Medical Cannabis	PRICE SENSITIVE	05/02/24	762.42KB	Share
BXN	Quarterly Report Listing Rule 4.7C.3		05/02/24	661.24KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/01/24	965.25KB	Share
BXN	Final Director's Interest Notice		17/11/23	141.7KB	Share
BXN	Retirement of Director	PRICE SENSITIVE	17/11/23	564.48KB	Share
BXN	Results of Meeting		17/11/23	586.31KB	Share
BXN	Annual General Meeting Presentation		17/11/23	7.69MB	Share
BXN	Change in substantial holding		06/11/23	156.14KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	988.5KB	Share
BXN	BLS Builds Medicinal Business In Australia		19/10/23	614.62KB	Share
BXN	Letter to Shareholders re Annual General Meeting Notice		18/10/23	608.01KB	Share
BXN	Notice of Annual General Meeting/Proxy Form		18/10/23	406.33KB	Share
BXN	Change of Director's Interest Notice		17/10/23	237.76KB	Share
BXN	Change of Director's Interest Notice		09/10/23	170.73KB	Share
BXN	AGM Date 2023 and Closing Date for Director Nominations		05/10/23	537.66KB	Share
BXN	Annual Report to shareholders		29/09/23	1.74MB	Share
BXN	Appendix 4G and Corporate Governance Statement		29/09/23	669.01KB	Share
BXN	Preliminary Final Report	PRICE SENSITIVE	31/08/23	603.85KB	Share
BXN	Bioxyne Signs Joint Venture with CanXChange		15/08/23	586.37KB	Share
BXN	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	989.05KB	Share
BXN	BLS Extends Amazon Footprint into US and Japan	PRICE SENSITIVE	17/07/23	632.66KB	Share
BXN	Bioxyne Launches BLS Clinics - Online Healthcare		13/06/23	628.43KB	Share
BXN	Becoming a substantial holder		08/06/23	214.36KB	Share
BXN	Becoming a substantial holder		31/05/23	1.22MB	Share
BXN	Change in substantial holding		31/05/23	508.15KB	Share
BXN	Notification regarding unquoted securities - BXN		25/05/23	27.97KB	Share
BXN	Ceasing to be a substantial holder X 2		23/05/23	4.07MB	Share
BXN	Becoming a substantial holder		23/05/23	261.87KB	Share
BXN	Becoming a substantial holder		23/05/23	17.74MB	Share
BXN	Final Directors Interest Notice X 2		23/05/23	295.52KB	Share
BXN	Initial Directors Interest Notice X 2		23/05/23	258.84KB	Share
BXN	Cleansing Notice		22/05/23	530.04KB	Share

BXN Bioxyne to Host Webinar 18 June 2025 at 5PM AEST
12/06/25		163.92KB	Share
BXN FY25 Revenue Guidance Upgrade
12/06/25	PRICE SENSITIVE	163.29KB	Share
BXN Invitation to Investor Webinar 1 May 2025 at 4PM AEST
30/04/25		242.31KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
28/04/25	PRICE SENSITIVE	521.79KB	Share
BXN Notification regarding unquoted securities - BXN
07/04/25		17.73KB	Share
BXN Notification regarding unquoted securities - BXN
07/04/25		17.73KB	Share
BXN Notification regarding unquoted securities - BXN
07/04/25		18.02KB	Share
BXN Prof Michael Barnes MD, FRCP Joins BXN Advisory Board
03/04/25		209.24KB	Share
BXN BXN Signs Exclusive $7m Manufacturing and Supply Agreement
03/04/25	PRICE SENSITIVE	205.72KB	Share
BXN Cleansing Notice
27/03/25		174.63KB	Share
BXN Application for quotation of securities - BXN
27/03/25		15.64KB	Share
BXN Proposed issue of securities - BXN
21/03/25		15.93KB	Share
BXN Proposed issue of securities - BXN
21/03/25		15.98KB	Share
BXN Proposed issue of securities - BXN
21/03/25		18.55KB	Share
BXN Bioxyne Raises A$3 million in Capital Raise
21/03/25	PRICE SENSITIVE	267.09KB	Share
BXN Trading Halt
19/03/25	PRICE SENSITIVE	203.74KB	Share
BXN Pause in Trading
19/03/25	PRICE SENSITIVE	113.73KB	Share
BXN Bioxyne Investor Webinar 5 March
04/03/25		243.8KB	Share
BXN BXN H1 FY25 Results Presentation
28/02/25	PRICE SENSITIVE	2.06MB	Share
BXN Half Yearly Report and Accounts
28/02/25	PRICE SENSITIVE	2.2MB	Share
BXN Quarterly Activities Report December 2024 Revised
28/01/25	PRICE SENSITIVE	496.25KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
28/01/25	PRICE SENSITIVE	445.81KB	Share
BXN Revenue Guidance
23/01/25	PRICE SENSITIVE	270.77KB	Share
BXN Addendum to Presentation dated 18 November 2024
14/01/25	PRICE SENSITIVE	187.03KB	Share
BXN Change of Directors Interest Notice X 3
19/12/24		244.59KB	Share
BXN Notification regarding unquoted securities - BXN
19/12/24		16.86KB	Share
BXN Notification of cessation of securities - BXN
19/12/24		12.66KB	Share
BXN Notification regarding unquoted securities - BXN
19/12/24		18.16KB	Share
BXN Response to ASX Price Query
28/11/24	PRICE SENSITIVE	1.27MB	Share
BXN Results of Meeting Revised
27/11/24		655.14KB	Share
BXN Results of Meeting
21/11/24		600.14KB	Share
BXN Investor Presentation November 2024
18/11/24	PRICE SENSITIVE	1.94MB	Share
BXN AGM Change of Venue and Registration
18/11/24		669.18KB	Share
BXN Cleansing Notice
08/11/24		677.22KB	Share
BXN Notification regarding unquoted securities - BXN
01/11/24		15.56KB	Share
BXN Application for quotation of securities - BXN
01/11/24		16.8KB	Share
BXN Letter to Shareholders re Notice of Annual General Meeting
22/10/24		610.24KB	Share
BXN Notice of Annual General Meeting/Proxy Form
22/10/24		559.05KB	Share
BXN Investor Presentation Update
17/10/24	PRICE SENSITIVE	2.17MB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
17/10/24	PRICE SENSITIVE	501.16KB	Share
BXN AGM Date and Director Nominations
04/10/24		185.21KB	Share
BXN Annual Report to shareholders
30/09/24		2.08MB	Share
BXN Appendix 4G - Corporate Governance Statement
30/09/24		610.58KB	Share
BXN Bioxyne Investor Webinar 25 September 2024
24/09/24		228.25KB	Share
BXN Bioxyne Extends Contract with Aura Therapeutics
24/09/24	PRICE SENSITIVE	179.74KB	Share
BXN JMM Webinar Presentation
18/09/24		3.22MB	Share
BXN Response to ASX Aware Query
18/09/24	PRICE SENSITIVE	1.26MB	Share
BXN Reinstatement to Quotation
18/09/24	PRICE SENSITIVE	87.92KB	Share
BXN Announcement 21.8.2024 Clarifying Statement
18/09/24	PRICE SENSITIVE	219.98KB	Share
BXN Suspension from Official Quotation
13/09/24	PRICE SENSITIVE	110.25KB	Share
BXN Preliminary Final Report
30/08/24	PRICE SENSITIVE	607.71KB	Share
BXN Response to ASX Query Letter
23/08/24	PRICE SENSITIVE	1.29MB	Share
BXN Pause in Trading
23/08/24	PRICE SENSITIVE	116.54KB	Share
BXN BXN Manufactures First Pharmaceutical Cannabis Gummies
21/08/24	PRICE SENSITIVE	183.66KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
30/07/24	PRICE SENSITIVE	1.02MB	Share
BXN Addendum to Cy Biopharma Announcement 14.5.2024
01/07/24		253.63KB	Share
BXN BXN Signs Collaboration Agreement with Cy Biopharma AG
14/05/24		290.26KB	Share
BXN Shares Out of Escrow
13/05/24		647.43KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	985.45KB	Share
BXN Cleansing Notice
22/04/24		675.74KB	Share
BXN Application for quotation of securities - BXN
22/04/24		15.39KB	Share
BXN Proposed issue of securities - BXN
18/04/24		15.15KB	Share
BXN Bioxyne Receives Firm Commitments to Raise $1.45 Million
18/04/24		702.1KB	Share
BXN Bioxyne to Host Webinar on 28 March 2024
25/03/24		667.26KB	Share
BXN Investor Presentation
25/03/24		4.86MB	Share
BXN Notification regarding unquoted securities - BXN
22/03/24		15.56KB	Share
BXN Notification of cessation of securities - BXN
22/03/24		12.69KB	Share
BXN Half Yearly Report and Accounts
29/02/24	PRICE SENSITIVE	2.39MB	Share
BXN BXN Awarded GMP Manufacturing License for Medical Cannabis
05/02/24	PRICE SENSITIVE	762.42KB	Share
BXN Quarterly Report Listing Rule 4.7C.3
05/02/24		661.24KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
29/01/24	PRICE SENSITIVE	965.25KB	Share
BXN Final Director's Interest Notice
17/11/23		141.7KB	Share
BXN Retirement of Director
17/11/23	PRICE SENSITIVE	564.48KB	Share
BXN Results of Meeting
17/11/23		586.31KB	Share
BXN Annual General Meeting Presentation
17/11/23		7.69MB	Share
BXN Change in substantial holding
06/11/23		156.14KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	988.5KB	Share
BXN BLS Builds Medicinal Business In Australia
19/10/23		614.62KB	Share
BXN Letter to Shareholders re Annual General Meeting Notice
18/10/23		608.01KB	Share
BXN Notice of Annual General Meeting/Proxy Form
18/10/23		406.33KB	Share
BXN Change of Director's Interest Notice
17/10/23		237.76KB	Share
BXN Change of Director's Interest Notice
09/10/23		170.73KB	Share
BXN AGM Date 2023 and Closing Date for Director Nominations
05/10/23		537.66KB	Share
BXN Annual Report to shareholders
29/09/23		1.74MB	Share
BXN Appendix 4G and Corporate Governance Statement
29/09/23		669.01KB	Share
BXN Preliminary Final Report
31/08/23	PRICE SENSITIVE	603.85KB	Share
BXN Bioxyne Signs Joint Venture with CanXChange
15/08/23		586.37KB	Share
BXN Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	989.05KB	Share
BXN BLS Extends Amazon Footprint into US and Japan
17/07/23	PRICE SENSITIVE	632.66KB	Share
BXN Bioxyne Launches BLS Clinics - Online Healthcare
13/06/23		628.43KB	Share
BXN Becoming a substantial holder
08/06/23		214.36KB	Share
BXN Becoming a substantial holder
31/05/23		1.22MB	Share
BXN Change in substantial holding
31/05/23		508.15KB	Share
BXN Notification regarding unquoted securities - BXN
25/05/23		27.97KB	Share
BXN Ceasing to be a substantial holder X 2
23/05/23		4.07MB	Share
BXN Becoming a substantial holder
23/05/23		261.87KB	Share
BXN Becoming a substantial holder
23/05/23		17.74MB	Share
BXN Final Directors Interest Notice X 2
23/05/23		295.52KB	Share
BXN Initial Directors Interest Notice X 2
23/05/23		258.84KB	Share
BXN Cleansing Notice
22/05/23		530.04KB	Share

REFRESH

1 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.7¢		Change -0.004(12.9%)		Mkt cap ! $58.45M

Open	High	Low	Value	Volume
3.1¢	3.2¢	2.7¢	$249.2K	8.379M

Buyers (Bids)

No.	Vol.	Price($)
5	1096318	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
2.9¢	150000	1

View Market Depth

No.	Vol.	Price($)
4	937059	0.027
7	1944230	0.026
12	1770185	0.025
8	3261929	0.024
3	354500	0.023

Price($)	Vol.	No.
0.029	150000	1
0.030	251214	1
0.031	689483	1
0.032	312042	1
0.033	600000	1

Last trade - 16.10pm 13/06/2025 (20 minute delay)

BXN (ASX) Chart

BIOXYNE LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories